Matrix Metalloproteinases as Drug Targets in Infections Caused by Gram-Negative Bacteria and in Septic Shock
暂无分享,去创建一个
[1] K. Bodger,et al. Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine Helicobacter infection , 2007, Journal of Clinical Pathology.
[2] G. Opdenakker,et al. Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis. , 2008, FEMS immunology and medical microbiology.
[3] J. Klossek,et al. Pseudomonas Aeruginosa Virulence Factors Delay Airway Epithelial Wound Repair by Altering the Actin Cytoskeleton and Inducing Overactivation of Epithelial Matrix Metalloproteinase–2 , 2000, Laboratory Investigation.
[4] J. Platt,et al. Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 41 , 2004, The Journal of Immunology.
[5] P. E. Van den Steen,et al. Inhibition of lethal endotoxin shock with an L-pyridylalanine containing metalloproteinase inhibitor selected by high-throughput screening of a new peptide library. , 2006, Combinatorial chemistry & high throughput screening.
[6] Tao Xu,et al. The role of neutrophil collagenase in endotoxic acute lung injury. , 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[7] B. Haynes,et al. Resistance of CD7-deficient Mice to Lipopolysaccharide-induced Shock Syndromes , 1999, The Journal of experimental medicine.
[8] R. Dellinger,et al. Treatment options for severe sepsis and septic shock , 2006, Expert review of anti-infective therapy.
[9] P. E. Van den Steen,et al. Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. , 2005, Biochemical pharmacology.
[10] L. Brown,et al. Ethanol ingestion increases activation of matrix metalloproteinases in rat lungs during acute endotoxemia. , 1999, American journal of respiratory and critical care medicine.
[11] C. Janeway,et al. Introduction: the role of innate immunity in the adaptive immune response , 1998, Seminars in immunology.
[12] L. Rather,et al. Disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by Galen to the four cardinal signs of Celsus. , 1971, Bulletin of the New York Academy of Medicine.
[13] M. Imtiaz,et al. A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice. , 2007, Microbes and infection.
[14] Jonathan Cohen. The immunopathogenesis of sepsis , 2002, Nature.
[15] G. Dougan,et al. Impaired Immunity to Intestinal Bacterial Infection in Stromelysin-1 (Matrix Metalloproteinase-3)-Deficient Mice1 , 2004, The Journal of Immunology.
[16] Marian F Young,et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. , 2005, The Journal of clinical investigation.
[17] M. Lalu,et al. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: A potential role for MMP-9 , 2003, Molecular and Cellular Biochemistry.
[18] Jerome F. Strauss,et al. The Extra Domain A of Fibronectin Activates Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.
[19] M. Sitkovsky,et al. Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.
[20] C. Brinckerhoff,et al. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. , 1992, Journal of cellular biochemistry.
[21] M. Lalu,et al. Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia , 2004, Critical care medicine.
[22] J. Dhainaut,et al. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. , 1999, American journal of respiratory and critical care medicine.
[23] C. Overall,et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. , 2008, Blood.
[24] Ivan Stamenkovic,et al. Extracellular matrix remodelling: the role of matrix metalloproteinases , 2003, The Journal of pathology.
[25] X. Puente,et al. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. , 1996, Cancer research.
[26] S. Landas,et al. CHEMICALLY MODIFIED TETRACYCLINE (COL-3) IMPROVES SURVIVAL IF GIVEN 12 BUT NOT 24 HOURS AFTER CECAL LIGATION AND PUNCTURE , 2006, Shock.
[27] Keiko Ozato,et al. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. , 2002, BioTechniques.
[28] M. Borggrefe,et al. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: Prognostic value of TIMP-1 in severe sepsis , 2006, Scandinavian journal of infectious diseases.
[29] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[30] J. Varani,et al. Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases. , 1999, American journal of respiratory cell and molecular biology.
[31] Kyung-Chan Kim,et al. MAP Kinase activation is required for the MMP-9 induction by TNF-stimulation , 2005, Archives of pharmacal research.
[32] P. Libby,et al. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. , 1998, Journal of immunology.
[33] B. Fingleton,et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.
[34] L. Matrisian,et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. , 1999, Science.
[35] Kirby I Bland,et al. CECAL LIGATION AND PUNCTURE , 2005, Shock.
[36] T. Standiford,et al. Anti-Tumor Necrosis Factor-&agr; Therapy During Murine Klebsiella pneumoniae Bacteremia: Increased Mortality in the Absence of Liver Injury , 2003, Shock.
[37] N. Webster,et al. Matrix metalloproteinase‐9 concentrations in critically ill patients , 2001, Anaesthesia.
[38] S. Mita,et al. Differential effects between marimastat, a TNF-α converting enzyme inhibitor, and anti-TNF-α antibody on murine models for sepsis and arthritis , 2002 .
[39] E. Cillari,et al. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood , 1997, Antimicrobial agents and chemotherapy.
[40] M. Sung,et al. Matrix metalloproteinase‐2 (MMP‐2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP‐ribose) polymerase (PARP) in vitro , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] J. Cohen. Mechanisms of Tissue Injury in Sepsis: Contrasts between Gram Positive and Gram Negative Infection , 2001, Journal of chemotherapy.
[42] T. Mak,et al. Cutting Edge: Tissue Inhibitor of Metalloproteinase 3 Regulates TNF-Dependent Systemic Inflammation , 2006, The Journal of Immunology.
[43] Jonathan Cohen,et al. The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit , 2005, Critical care medicine.
[44] M. Rojas,et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. , 2005, Gastroenterology.
[45] P. Berna,et al. Effects of depletion of neutrophils or macrophages on the inflammatory response induced by metalloelastase (MMP-12) in mice airways. , 2008, European journal of pharmacology.
[46] C. Brinckerhoff,et al. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. , 1996, Gene expression.
[47] M. Menger,et al. Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of D‐galactosamine‐sensitized mice to lipopolysaccharide , 2007, British journal of pharmacology.
[48] B. Haye,et al. TIMPs as multifacial proteins. , 2004, Critical reviews in oncology/hematology.
[49] S. Mita,et al. Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis. , 2002, Cytokine.
[50] R. Veldhuizen,et al. Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation, and hyperoxia. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[51] R. Veldhuizen,et al. Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[52] L. Hazlett,et al. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection. , 2006, Investigative ophthalmology & visual science.
[53] D. Remick,et al. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. , 2000, Shock.
[54] M. Imtiaz,et al. Inhibition of Matrix Metalloproteinases Protects Mice from Ascending Infection and Chronic Disease Manifestations Resulting from Urogenital Chlamydia muridarum Infection , 2006, Infection and Immunity.
[55] G. Rosenberg,et al. Stromelysin-1 and gelatinase A are upregulated before TNF-α in LPS-stimulated neuroinflammation , 2002, Brain Research.
[56] G. Rosenberg,et al. Blood–brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation , 2006, Neurobiology of Disease.
[57] B. Beutler,et al. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. , 2008, Immunobiology.
[58] David B. Alexander,et al. The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis , 2001, Cell.
[59] Marie M. Lee,et al. Tissue Inhibitor of Metalloproteinase 1 Regulates Resistance to Infection , 2005, Infection and Immunity.
[60] C. Elson,et al. A Novel Role for Defensins in Intestinal Homeostasis: Regulation of IL-1β Secretion1 , 2007, The Journal of Immunology.
[61] B. Mecham,et al. Individual Matrix Metalloproteinases Control Distinct Transcriptional Responses in Airway Epithelial Cells Infected with Pseudomonas aeruginosa , 2007, Infection and Immunity.
[62] N. Oku,et al. Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP. , 2003, Biological & pharmaceutical bulletin.
[63] C. Liang,et al. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. , 1999, American journal of respiratory cell and molecular biology.
[64] J. Vincent. Drotrecogin alfa (activated): the treatment for severe sepsis? , 2007, Current drug safety.
[65] S. Wessler,et al. p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7. , 2008, Molecular biology of the cell.
[66] P. Libby,et al. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. , 1998, Circulation.
[67] E. Peterson,et al. Role of matrix metalloproteinase‐7 in the modulation of a Chlamydia trachomatis infection , 2006, Immunology.
[68] W. Parks,et al. Epilysin, a Novel Human Matrix Metalloproteinase (MMP-28) Expressed in Testis and Keratinocytes and in Response to Injury* , 2001, The Journal of Biological Chemistry.
[69] P. Berna,et al. Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat. , 2007, European journal of pharmacology.
[70] U. Shankavaram,et al. Differential Regulation of Lipopolysaccharide-Induced Monocyte Matrix Metalloproteinase (MMP)-1 and MMP-9 by p38 and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinases , 2003, The Journal of Immunology.
[71] S. Handley,et al. General and specific host responses to bacterial infection in Peyer's patches: a role for stromelysin‐1 (matrix metalloproteinase‐3) during Salmonella enterica infection , 2007, Molecular microbiology.
[72] T. Sato,et al. Activation of human progelatinase A/promatrix metalloproteinase 2 by Escherichia coli-derived serine proteinase. , 2000, Biochemical and biophysical research communications.
[73] D. Gingras,et al. Matrix metalloproteinase inhibition by green tea catechins. , 2000, Biochimica et biophysica acta.
[74] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[75] A. Noël,et al. Resistance of Collagenase-2 (Matrix Metalloproteinase-8)-Deficient Mice to TNF-Induced Lethal Hepatitis1 , 2005, The Journal of Immunology.
[76] Schroen Dj,et al. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. , 1996 .
[77] J. Friedland,et al. The paradox of matrix metalloproteinases in infectious disease , 2005, Clinical and experimental immunology.
[78] C. Sprung,et al. Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.
[79] P. Soloway,et al. Hyper‐resistance to Infection in TIMP‐1‐Deficient Mice Is Neutrophil Dependent but Not Immune Cell Autonomous , 1999, Annals of the New York Academy of Sciences.
[80] L. Moldawer,et al. A MATRIX METALLOPROTEINASE INHIBITOR PREVENTS PROCESSING OF TUMOR NECROSIS FACTOR α (TNFα) AND ABROGATES ENDOTOXIN‐INDUCED LETHALITY , 1997 .
[81] A. H. Drummond,et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. , 1994, Nature.
[82] W. Parks,et al. Control of matrix metalloproteinase catalytic activity. , 2007, Matrix biology : journal of the International Society for Matrix Biology.
[83] L. Joosten,et al. Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways , 2001, European journal of immunology.
[84] S. Shapiro,et al. Macrophage elastase prevents Gemella morbillorum infection and improves outcome following murine bone marrow transplantation. , 1999, Chest.
[85] G. Koh,et al. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. , 2000, Biochemical and biophysical research communications.
[86] T. Poll,et al. Animal and human models for sepsis , 2002, Annals of medicine.
[87] J. Marshall,et al. PRECLINICAL MODELS OF SHOCK AND SEPSIS: WHAT CAN THEY TELL US? , 2005, Shock.
[88] Christine E. Becker,et al. Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs , 2007, Seminars in Immunopathology.
[89] William C. Parks,et al. Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.
[90] H. Birkedal‐Hansen,et al. MT1‐MMP: A tethered collagenase , 2004, Journal of cellular physiology.
[91] J. Wrana,et al. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. , 1991, The Journal of biological chemistry.
[92] E. Deitch. ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED , 1998, Shock.
[93] V. Pettilä,et al. COLLAGENASE 2/MATRIX METALLOPROTEINASE 8 IN CRITICALLY ILL PATIENTS WITH SECONDARY PERITONITIS , 2007, Shock.
[94] S. Husson,et al. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. , 2003, Biochemical and biophysical research communications.
[95] Younghee Lee,et al. NF-kappaB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264.7. , 2007, Journal of biochemistry and molecular biology.
[96] M. Milla,et al. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. , 2002, Biochemistry.
[97] L. Moldawer,et al. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[98] K. Bodger,et al. The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori. , 2006, Gastroenterology.
[99] J. Platt,et al. Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 41 , 2002, The Journal of Immunology.
[100] Anne M Manicone,et al. Matrix metalloproteinases as modulators of inflammation. , 2008, Seminars in cell & developmental biology.
[101] K. Triantafilou,et al. The dynamics of LPS recognition: complex orchestration of multiple receptors , 2005 .
[102] J. Gordon,et al. Bacterial Exposure Induces and Activates Matrilysin in Mucosal Epithelial Cells , 2000, The Journal of cell biology.
[103] J. Platt,et al. Conditional signaling by Toll‐like receptor 4 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[104] G. Rosenberg,et al. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[105] K. Kirkwood,et al. Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase , 2007, Journal of endotoxin research.
[106] H. Matsuda,et al. Mast cell MMP-9 production enhanced by bacterial lipopolysaccharide. , 2001, The Journal of veterinary medical science.
[107] P. Libby,et al. Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.
[108] Jialiang Hu,et al. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases , 2007, Nature Reviews Drug Discovery.
[109] J. Cavaillon,et al. Cytokine Cascade in Sepsis , 2003, Scandinavian journal of infectious diseases.
[110] G. Rosenberg,et al. Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. , 2002, Brain research.
[111] Stephen J. Weiss,et al. Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.
[112] Mark R. Wilson,et al. Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity. , 2008, Biochemistry.
[113] C. Brinckerhoff,et al. Post‐Transcriptional regulationa of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts , 1992 .
[114] V. Lagente,et al. Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide. , 1999, Pulmonary pharmacology & therapeutics.
[115] C. Overall,et al. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. , 2008, The American journal of pathology.
[116] M. Lalu,et al. Matrix metalloproteinases contribute to endotoxin and interleukin‐1β induced vascular dysfunction , 2006, British journal of pharmacology.
[117] S. Tanase,et al. Activation of Human Matrix Metalloproteinases by Various Bacterial Proteinases* , 1997, The Journal of Biological Chemistry.
[118] M. Madigan,et al. Brock Biology of Microorganisms , 1996 .
[119] P. Bollaert. Corticosteroids for septic shock. , 2008, The New England journal of medicine.
[120] Rather Lj. Disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by Galen to the four cardinal signs of Celsus. , 1971 .
[121] M. Kaplan,et al. The Gram Stain and Differential Staining , 1933, Journal of bacteriology.
[122] K. Cohoon,et al. Expression of Matrix Metalloproteinases Subsequent to Urogenital Chlamydia muridarum Infection of Mice , 2005, Infection and Immunity.
[123] J. Shim,et al. Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[124] T. Ahrens,et al. Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4 , 2002, The Journal of experimental medicine.
[125] A. Sparreboom,et al. Chemically modified tetracyclines as inhibitors of matrix metalloproteinases. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[126] S. Maitra,et al. Inhibition of Matrix Metalloproteinases by Chemically Modified Tetracyclines in Sepsis , 2003, Shock.
[127] S. Hultgren,et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998, Science.
[128] L. Moldawer,et al. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. , 1997, Shock.
[129] K. Pfeffer,et al. CECAL LIGATION AND PUNCTURE VERSUS COLON ASCENDENS STENT PERITONITIS: TWO DISTINCT ANIMAL MODELS FOR POLYMICROBIAL SEPSIS , 2004, Shock.
[130] S. Landas,et al. Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. , 2003, The Journal of surgical research.
[131] M. Bianchi. DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.
[132] R. Andriantsitohaina,et al. Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice. , 2007, The American journal of pathology.
[133] B. Beutler,et al. Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.
[134] C. López-Otín,et al. Membrane-Bound Matrix Metalloproteinase-8 on Activated Polymorphonuclear Cells Is a Potent, Tissue Inhibitor of Metalloproteinase-Resistant Collagenase and Serpinase1 , 2004, The Journal of Immunology.
[135] H. Nguyen,et al. Sepsis in the 21st century: recent definitions and therapeutic advances. , 2007, American Journal of Emergency Medicine.
[136] D. Berg,et al. Cag Pathogenicity Island-independent Up-regulation of Matrix Metalloproteinases-9 and -2 Secretion and Expression in Mice by Helicobacter pylori Infection* , 2006, Journal of Biological Chemistry.
[137] C. Jackson,et al. The dual personalities of matrix metalloproteinases in inflammation. , 2007, Frontiers in bioscience : a journal and virtual library.
[138] L. He,et al. Mesenchymal stem cell‐based angiopoietin‐1 gene therapy for acute lung injury induced by lipopolysaccharide in mice , 2007, The Journal of pathology.
[139] T. Nakamura,et al. Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment. , 1998, The American journal of the medical sciences.
[140] D. Kwiatkowski,et al. A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection , 2006, BMC Medical Genetics.
[141] W. Parks,et al. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. , 1995, Journal of immunology.
[142] L. Shapira,et al. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion , 1996, Infection and immunity.
[143] V. Perry,et al. Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.
[144] X. Puente,et al. LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity , 2007, PloS one.
[145] Gerald Maurer,et al. Catecholamines potentiate LPS‐induced expression of MMP‐1 and MMP‐9 in human monocytes and in the human monocytic cell line U937: possible implications for peri‐ operative plaque instability , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[146] Carsten J. Kirschning,et al. HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway* , 2002, The Journal of Biological Chemistry.
[147] S. Opal. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. , 2007, International journal of medical microbiology : IJMM.
[148] J. Varani,et al. Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. , 2004, Experimental and molecular pathology.
[149] G. Opdenakker,et al. Gelatinase B deficiency protects against endotoxin shock , 2002, European journal of immunology.
[150] T. Pruett. Matrix Metalloproteinase-9 Deficiency Impairs Host Defense against Abdominal Sepsis , 2007 .
[151] Charles J Malemud,et al. Matrix metalloproteinases (MMPs) in health and disease: an overview. , 2006, Frontiers in bioscience : a journal and virtual library.
[152] W. Hancock,et al. Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 41 , 2001, The Journal of Immunology.
[153] T. Betsuyaku,et al. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. , 1999, American journal of respiratory cell and molecular biology.
[154] A. Stalder,et al. Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice. , 2000, The American journal of pathology.
[155] A. Mantovani,et al. Toll-like receptor family and signalling pathway. , 2000, Biochemical Society transactions.
[156] B. Cauwe,et al. The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases , 2007, Critical reviews in biochemistry and molecular biology.
[157] A. Sollevi,et al. Differential release of matrix metalloproteinase‐9 and nitric oxide following infusion of endotoxin to human volunteers , 2003, Acta anaesthesiologica Scandinavica.
[158] M. Lucia,et al. Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. , 2004, American journal of physiology. Renal physiology.
[159] W. Parks,et al. Regulation of Matrilysin Expression in Airway Epithelial Cells by Pseudomonas aeruginosa Flagellin* , 2001, The Journal of Biological Chemistry.
[160] S. Mobashery,et al. Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood–brain barrier opening in rodents: Differences in response based on strains and solvents , 2007, Brain Research.
[161] J. Shukla,et al. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock. , 2007, The Journal of surgical research.
[162] C. Libert,et al. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation , 2007, Journal of leukocyte biology.
[163] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[164] P. Gottschall,et al. Increased production of gelatinase B (matrix metalloproteinase‐9) and interleukin‐6 by activated rat microglia in culture , 1995, Journal of neuroscience research.